267 related articles for article (PubMed ID: 9736323)
21. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
[TBL] [Abstract][Full Text] [Related]
22. Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus.
Karimifar M; Tahmasebi A; Bonakdar ZS; Purajam S
Rheumatol Int; 2013 Feb; 33(2):511-6. PubMed ID: 22065074
[TBL] [Abstract][Full Text] [Related]
23. Hyperprolactinemia in systemic lupus erythematosus.
Huang CM; Chou CT
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jan; 59(1):37-41. PubMed ID: 9134821
[TBL] [Abstract][Full Text] [Related]
24. Prolactin has a pathogenic role in systemic lupus erythematosus.
Jara LJ; Medina G; Saavedra MA; Vera-Lastra O; Torres-Aguilar H; Navarro C; Vazquez Del Mercado M; Espinoza LR
Immunol Res; 2017 Apr; 65(2):512-523. PubMed ID: 28130617
[TBL] [Abstract][Full Text] [Related]
25. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients.
Mok CC; Lau CS; Tam SC
Br J Rheumatol; 1997 Sep; 36(9):986-9. PubMed ID: 9376996
[TBL] [Abstract][Full Text] [Related]
26. Prolactin and autoimmunity.
De Bellis A; Bizzarro A; Pivonello R; Lombardi G; Bellastella A
Pituitary; 2005; 8(1):25-30. PubMed ID: 16411065
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin.
Méndez I; Alcocer-Varela J; Parra A; Lava-Zavala A; de la Cruz DA; Alarcón-Segovia D; Larrea F
Lupus; 2004; 13(1):45-53. PubMed ID: 14870917
[TBL] [Abstract][Full Text] [Related]
28. Prolactin levels and autoantibodies in female patients with systemic lupus erythematosus.
Kozáková D; Rovenský J; Cebecauer L; Bosák V; Jahnová E; Vigas M
Z Rheumatol; 2000; 59 Suppl 2():II/80-4. PubMed ID: 11155810
[TBL] [Abstract][Full Text] [Related]
29. Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
Hattori N; Nakayama Y; Kitagawa K; Li T; Inagaki C
Endocrinology; 2007 May; 148(5):2465-70. PubMed ID: 17303669
[TBL] [Abstract][Full Text] [Related]
30. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study.
Jimena P; Aguirre MA; López-Curbelo A; de Andrés M; Garcia-Courtay C; Cuadrado MJ
Lupus; 1998; 7(6):383-6. PubMed ID: 9736320
[TBL] [Abstract][Full Text] [Related]
31. Correlation between serum prolactin levels and lupus activity.
Rezaieyazdi Z; Hesamifard A
Rheumatol Int; 2006 Sep; 26(11):1036-9. PubMed ID: 16625339
[TBL] [Abstract][Full Text] [Related]
32. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations.
El-Garf A; Salah S; Shaarawy M; Zaki S; Anwer S
J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050
[TBL] [Abstract][Full Text] [Related]
33. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
Hattori N; Inagaki C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
[TBL] [Abstract][Full Text] [Related]
34. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.
Orbach H; Zandman-Goddard G; Boaz M; Agmon-Levin N; Amital H; Szekanecz Z; Szucs G; Rovensky J; Kiss E; Doria A; Ghirardello A; Gomez-Arbesu J; Stojanovich L; Ingegnoli F; Meroni PL; Rozman B; Blank M; Shoenfeld Y
Clin Rev Allergy Immunol; 2012 Apr; 42(2):189-98. PubMed ID: 21287295
[TBL] [Abstract][Full Text] [Related]
35. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
[TBL] [Abstract][Full Text] [Related]
36. Correlation between Systemic Lupus Erythematosus Activity and Plasma Levels of Monomeric Prolactin and Macroprolactin.
Toffoli Ribeiro C; Louzada Júnior P; de Sá MF
Endocr Metab Immune Disord Drug Targets; 2016; 16(1):21-7. PubMed ID: 27237539
[TBL] [Abstract][Full Text] [Related]
37. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
Vera-Lastra O; Mendez C; Jara LJ; Cisneros M; Medina G; Ariza R; Espinoza LR
J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
[TBL] [Abstract][Full Text] [Related]
38. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease.
Allen SH; Sharp GC; Wang G; Conley C; Takeda Y; Conroy SE; Walker SE
Lupus; 1996 Feb; 5(1):30-7. PubMed ID: 8646222
[TBL] [Abstract][Full Text] [Related]
39. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity.
Jara LJ; Gomez-Sanchez C; Silveira LH; Martinez-Osuna P; Vasey FB; Espinoza LR
Am J Med Sci; 1992 Apr; 303(4):222-6. PubMed ID: 1562038
[TBL] [Abstract][Full Text] [Related]
40. Association of raised levels of IL-4 and anti-TPO with hyperprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Mathew M; Sharma JB
Am J Reprod Immunol; 2019 Mar; 81(3):e13085. PubMed ID: 30614113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
